Evaluating Cholesterol Biomarker, Treatment, and Socio-Demographic Factors as Indicators of Opioid Use Disorder Treatment Retention
Contact Hours: 0.75
This interactive presentation introduces supporting evidence on clinical use of cholesterol biomarker and integrated health service provision in opioid treatment program to promote retention of minority patients.